AbSci’s Acquisition of Totient

Wilson Sonsini Goodrich & Rosati advised Totient on the deal.AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced the acquisition of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here